首页> 外文期刊>Chemicke Zvesti >Iron cross-linked carboxymethyl cellulose-gelatin complex coacervate beads for sustained drug delivery
【24h】

Iron cross-linked carboxymethyl cellulose-gelatin complex coacervate beads for sustained drug delivery

机译:铁交联的羧甲基纤维素-明胶复合凝聚小球,用于持续给药

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The formation and smooth recovery of ibuprofen encapsulated in microcapsules using gelatin and carboxymethyl cellulose (CMC) complex coacervation without glutaraldehyde were the objectives of this investigation. The microcapsules were recovered as ionically cross-linked beads using aqueous ferric chloride in 50 vol. % of 2-propanol. A physical mixture of CMC/gelatin (FP1) and CMC alone (FP2) beads was also prepared for comparison. The drug-entrapment efficiency of complex coacervate beads (FP3-FP5) was dependent on the drug-to-polymer ratio and was in the range of 86-92 mass %. Beads prepared with the highest ratio of the drug (FP5) exhibited the lowest entrapment. FP1 and FP2 beads exhibited an entrapment efficiency of 98.5 mass % and 91.3 mass %, respectively. Infrared spectroscopy (FTIR) revealed different functional groups in complex coacervate, physical mixture and FP2 beads. Optical and scanning electron microscopy revealed the distinct appearance and surface morphology of the various beads. The stable and crystalline nature of ibuprofen in the beads was confirmed by FTIR and differential scanning calorimetry (DSC), respectively. Ibuprofen release from FP1 and FP2 beads was very slow and unsuitable for oral delivery. The bead prepared by complex coacervation (FP5) showed a better release profile over 48 h and could be developed as a sustained drug delivery system. (C) 2015 Institute of Chemistry, Slovak Academy of Sciences
机译:本研究的目的是使用明胶和羧甲基纤维素(CMC)复合凝聚法在没有戊二醛的情况下微囊化布洛芬的形成和顺利回收。使用50体积%的氯化铁水溶液将微胶囊回收为离子交联的珠。 2-丙醇的%。还准备了CMC /明胶(FP1)和CMC单独(FP2)珠的物理混合物进行比较。复合凝聚层珠(FP3-FP5)的药物包封效率取决于药物与聚合物的比例,并且在86-92质量%的范围内。用最高比例的药物(FP5)制备的珠粒的包埋率最低。 FP1和FP2珠的包封率分别为98.5质量%和91.3质量%。红外光谱(FTIR)显示了复杂凝聚层,物理混合物和FP2珠粒中的不同官能团。光学和扫描电子显微镜揭示了各种珠粒的独特外观和表面形态。分别通过FTIR和差示扫描量热法(DSC)证实了布洛芬在微珠中的稳定和结晶性质。布洛芬从FP1和FP2磁珠释放的速度非常慢,因此不适合口服。通过复合凝聚(FP5)制备的珠子在48小时内显示出更好的释放特性,可以开发为持续的药物递送系统。 (C)2015年,斯洛伐克科学院化学研究所

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号